These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 22949815)

  • 21. Cancer-stromal interactions: role in cell survival, metabolism and drug sensitivity.
    Zhang W; Huang P
    Cancer Biol Ther; 2011 Jan; 11(2):150-6. PubMed ID: 21191189
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Three-dimensional Co-culture model for tumor-stromal interaction.
    Horie M; Saito A; Yamaguchi Y; Ohshima M; Nagase T
    J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncologic trogocytosis with Hospicells induces the expression of N-cadherin by breast cancer cells.
    Lis R; Capdet J; Mirshahi P; Lacroix-Triki M; Dagonnet F; Klein C; Mirshahi M; Fournié JJ; Rafii A; Poupot M
    Int J Oncol; 2010 Dec; 37(6):1453-61. PubMed ID: 21042713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fabrication Method of a High-Density Co-Culture Tumor-Stroma Platform to Study Cancer Progression.
    Saini H; Nikkhah M
    Methods Mol Biol; 2021; 2258():241-255. PubMed ID: 33340365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer.
    Xu S; Yang Z; Jin P; Yang X; Li X; Wei X; Wang Y; Long S; Zhang T; Chen G; Sun C; Ma D; Gao Q
    Mol Cancer Ther; 2018 Jun; 17(6):1291-1302. PubMed ID: 29545331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Tumor microenvironment and therapeutic resistance process].
    Borriello L; DeClerck YA
    Med Sci (Paris); 2014 Apr; 30(4):445-51. PubMed ID: 24801042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor-stroma interactions differentially alter drug sensitivity based on the origin of stromal cells.
    Landry BD; Leete T; Richards R; Cruz-Gordillo P; Schwartz HR; Honeywell ME; Ren G; Schwartz AD; Peyton SR; Lee MJ
    Mol Syst Biol; 2018 Aug; 14(8):e8322. PubMed ID: 30082272
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD44 expressed on cancer-associated fibroblasts is a functional molecule supporting the stemness and drug resistance of malignant cancer cells in the tumor microenvironment.
    Kinugasa Y; Matsui T; Takakura N
    Stem Cells; 2014 Jan; 32(1):145-56. PubMed ID: 24395741
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Understanding the role of stromal fibroblasts in cancer progression.
    Tripathi M; Billet S; Bhowmick NA
    Cell Adh Migr; 2012; 6(3):231-5. PubMed ID: 22568983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Multiaspect Functions of Periostin in Tumor Progression.
    Liu Y; Huang Z; Cui D; Ouyang G
    Adv Exp Med Biol; 2019; 1132():125-136. PubMed ID: 31037631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer.
    Hill BS; Sarnella A; D'Avino G; Zannetti A
    Semin Cancer Biol; 2020 Feb; 60():202-213. PubMed ID: 31377307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The mesenchymal tumor microenvironment: a drug-resistant niche.
    Cukierman E; Bassi DE
    Cell Adh Migr; 2012; 6(3):285-96. PubMed ID: 22568991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Landscape of extracellular vesicles in the tumour microenvironment: Interactions with stromal cells and with non-cell components, and impacts on metabolic reprogramming, horizontal transfer of neoplastic traits, and the emergence of therapeutic resistance.
    Zhang DX; Vu LT; Ismail NN; Le MTN; Grimson A
    Semin Cancer Biol; 2021 Sep; 74():24-44. PubMed ID: 33545339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Small molecules modulating tumor-stromal cell interactions: new candidates for anti-tumor drugs.
    Kawada M
    J Antibiot (Tokyo); 2016 Jun; 69(6):411-4. PubMed ID: 27005556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of tumour microenvironment: a new vision for cholangiocarcinoma.
    Chen Z; Guo P; Xie X; Yu H; Wang Y; Chen G
    J Cell Mol Med; 2019 Jan; 23(1):59-69. PubMed ID: 30394682
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronan: A modulator of the tumor microenvironment.
    Chanmee T; Ontong P; Itano N
    Cancer Lett; 2016 May; 375(1):20-30. PubMed ID: 26921785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adhesion to stromal cells mediates imatinib resistance in chronic myeloid leukemia through ERK and BMP signaling pathways.
    Kumar A; Bhattacharyya J; Jaganathan BG
    Sci Rep; 2017 Aug; 7(1):9535. PubMed ID: 28842696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can Targeting Stroma Pave the Way to Enhanced Antitumor Immunity and Immunotherapy of Solid Tumors?
    Puré E; Lo A
    Cancer Immunol Res; 2016 Apr; 4(4):269-78. PubMed ID: 27036971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GRP78 secreted by tumor cells stimulates differentiation of bone marrow mesenchymal stem cells to cancer-associated fibroblasts.
    Peng Y; Li Z; Li Z
    Biochem Biophys Res Commun; 2013 Nov; 440(4):558-63. PubMed ID: 24113381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.